ABCA7 rare variants and Alzheimer disease risk
- PMID: 27037229
- PMCID: PMC4898320
- DOI: 10.1212/WNL.0000000000002627
ABCA7 rare variants and Alzheimer disease risk
Abstract
Objective: To study the association between ABCA7 rare coding variants and Alzheimer disease (AD) in a case-control setting.
Methods: We conducted a whole exome analysis among 484 French patients with early-onset AD and 590 ethnically matched controls.
Results: After collapsing rare variants (minor allele frequency ≤1%), we detected an enrichment of ABCA7 loss of function (LOF) and predicted damaging missense variants in cases (odds ratio [OR] 3.40, 95% confidence interval [CI] 1.68-7.35, p = 0.0002). Performing a meta-analysis with previously published data, we found that in a combined sample of 1,256 patients and 1,347 controls from France and Belgium, the OR was 2.81 (95% CI 1.89-4.20, p = 3.60 × 10(-7)).
Conclusions: These results confirm that ABCA7 LOF variants are enriched in patients with AD and extend this finding to predicted damaging missense variants.
© 2016 American Academy of Neurology.
Comment in
-
Rare ABCA7 variants in Alzheimer disease: Guilt by association.Neurology. 2016 Jun 7;86(23):2118-9. doi: 10.1212/WNL.0000000000002630. Epub 2016 Apr 1. Neurology. 2016. PMID: 27037231 No abstract available.
References
-
- Pottier C, Hannequin D, Coutant S, et al. . High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry 2012;17:875–879. - PubMed
-
- Jonsson T, Atwal JK, Steinberg S, et al. . A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012;488:96–99. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical